IDENTIFICATION OF ENDOGENOUS SUPEROXIDE DISMUTASE AS A POTENTIAL INHIBITOR FOR PI3K AKT SIGNALING IN COLORECTAL CANCER - A MOLECULAR DOCKING STUDY. Journal of Pharmaceutical Negative Results 2022, 1374-1379. https://doi.org/10.47750/pnr.2022.13.S03.214.